sharecast

{{ storiesRelated.title }}

Headline News
26 Sep
Mutares tumbles as Gotham City highlights accounting irregularities

German private equity firm Mutares tumbled on Thursday after Gotham City Research put out a note pointing to accounting irregularities and suggesting that the company is "increasingly reliant" on debt.

26 Sep
dl morrisons wm morrison supermarket grocery retailer uk logo generic 1
Morrisons sales edge higher despite 'softer' market

Morrisons posted an uptick in third-quarter sales on Thursday, as it confirmed a £331m property deal intended to cut debts.

26 Sep
dl commerzbank ag germany bank banking finance logo generic
Commerzbank lifts financial targets

Germany’s Commerzbank reiterated plans to continuing growing as an independent bank on Thursday, including upping its financial targets, as it confirmed a first meeting with potential suitor UniCredit.

26 Sep
dl thames water water company ofwat tap water utility supplier logo 20231114 1241
Thames Water's credit ratings slashed

Thames Water has had its credit ratings cut even further, it was confirmed on Thursday, heaping yet more pressure on the crisis-struck utility.

26 Sep
h
H&M cuts 2024 earnings target, shares fall

Fashion giant Hennes & Mauritz cut its full-year margin target on Thursday, weighing on shares, after a "challenging" third quarter.

26 Sep
switzerland dl swiss
SNB cuts rates by 25 basis points to 1.0%

The Swiss National Bank cut interest rates on Thursday to 1. 0% from 1. 25%, in line with expectations.

26 Sep
dl halma ftse 100 industrials industrial goods and services electronic and electrincal equipment electronic equipment gauges and meters logo
Halma backs FY guidance after progress in first half

Halma backed its guidance for the full year on Thursday as it said further progress was made in the first half in trading conditions "which remain varied across our end markets".

26 Sep
dl astrazeneca ftse 100 astra zeneca health care healthcare pharmaceuticals and biotechnology pharmaceuticals logo
AstraZeneca's Tagrisso gets new US lung cancer approval

AstraZeneca announced on Thursday that ‘Tagrisso’, or osimertinib, has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, stage three epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), whose disease had not progressed after platinum-based chemoradiation therapy (CRT).

26 Sep
Mitchells and Butlers Nicholson's Nicholsons
Mitchells & Butlers Q4 sales hit by wet weather, UK riots

UK's pub group Mitchells & Butlers on Thursday said fourth-quarter like-for-like sales slowed as riots in city centres and an unseasonably wet summer hit trade but added that it still expected to deliver annual results at the upper end of consensus expectations.